Up 298% in a Year, Is Hims & Hers Health Still a Buy?
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Shares of Hims & Hers Health (NYSE: HIMS) have been on fire over the past year, but they’re not expensive by most valuation metrics, especially when you consider the company’s high growth rate. How much room is left to run? That’s what Travis Hoium discusses in this video.
:max_bytes(150000):strip_icc():format(jpeg)/WhatIsaRealEstateAppraiserDec.162021-ddb6a1aa97cc4f6686fd6f7ba9cfcca3.jpg "Reverse Mortgage Appraisal: What It Is, How It Works")
:max_bytes(150000):strip_icc():format(jpeg)/48126619532_f99720960b_k-4440c9ca18eb40d39353e807e7cd56ba.jpg "<div>FINRA vs. the SEC: What's the Difference?</div>")
